SBC Medical Group Holdings Incorporated

SBC Medical Group Holdings Incorporated

SBCWW
SBC Medical Group Holdings IncorporatedUS flagNASDAQ Global Market
0.24
USD
+0.00
- -
24.66MMarket Cap

Income Statement (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
174
194
205
174
+ Sales & Services Revenue
174
194
205
174
- Cost of Revenue
59
56
49
46
+ Cost of Goods & Services
59
56
49
46
Gross Profit
115
137
156
127
+ Other Operating Income
- -
- -
- -
- -
- Operating Expenses
93
66
71
60
+ Selling, General & Admin
93
66
71
60
+ Research & Development
- -
- -
- -
- -
+ Other Operating Expense
- -
- -
- -
- -
Operating Income (Loss)
21
71
85
67
- Non-Operating (Income) Loss
-2
-3
12
-15
+ Interest Expense, Net
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
-2
-2
12
-15
Pretax Income
24
74
73
82
- Income Tax Expense (Benefit)
18
35
27
31
- (Income) Loss from Affiliates
- -
- -
- -
- -
Income (Loss) from Cont Ops
6
39
47
51
- Net Extraordinary Losses (Gains)
-2
-2
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
+ Extraord. & Accounting Changes
-2
-2
- -
- -
Income (Loss) Incl. MI
7
40
47
51
- Minority Interest
1
1
- -
- -
Net Income, GAAP
6
39
47
51
- Preferred Dividends
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
Net Income Avail to Common, GAAP
6
39
47
51
EBIT
21
71
85
67
EBITDA
27
83
89
70
EBITDA Margin (%)
15.66
43.05
43.41
40.42
EBITA
21
71
85
67
Gross Margin (%)
65.94
70.94
75.97
73.32
Operating Margin (%)
12.26
36.72
41.56
38.87
Profit Margin (%)
3.63
20.34
22.69
29.37
Sales per Employee
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Depreciation Expense
6
12
4
3
Basic Weighted Avg Shares
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
Basic EPS from Cont Ops
- -
- -
- -
- -
Diluted Weighted Avg Shares
- -
- -
- -
- -
Diluted EPS, GAAP
- -
- -
- -
- -
Diluted EPS from Cont Ops
- -
- -
- -
- -

Balance Sheet (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
113
166
184
231
+ Cash, Cash Equivalents & STI
54
103
125
164
+ Cash & Cash Equivalents
52
103
125
164
+ ST Investments
2
- -
- -
- -
+ Accounts & Notes Receiv
44
53
48
53
+ Accounts Receivable, Net
13
35
30
30
+ Notes Receivable, Net
- -
1
- -
- -
+ Loans Receivable, Net
- -
8
10
9
+ Other Receivable, Net
31
9
8
14
+ Inventories
1
3
1
3
+ Raw Materials
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
+ Other Inventory
1
3
1
3
+ Other ST Assets
14
7
10
11
+ Misc ST Assets
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
Total Noncurrent Assets
113
93
82
149
+ Property, Plant & Equip, Net
22
20
14
16
+ Property, Plant & Equip
57
30
25
25
- Accumulated Depreciation
36
11
11
9
+ LT Investments & Receivables
1
21
21
39
+ LT Investments
1
21
21
39
+ LT Receivables
- -
- -
- -
- -
+ Other LT Assets
90
53
47
93
+ Total Intangible Assets
11
23
6
63
+ Goodwill
4
4
5
15
+ Other Intangible Assets
7
20
2
48
+ LT Deferred Tax Assets
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
+ Misc LT Assets
79
29
41
30
Total Assets
225
259
266
380
+ Payables & Accruals
37
59
44
35
+ Accounts Payable
15
27
15
18
+ Accrued Taxes
12
23
23
11
+ Interest & Dividends Payable
- -
- -
- -
- -
+ Other Payables & Accruals
11
10
6
7
+ ST Debt
8
7
4
14
+ ST Borrowings
5
4
- -
9
+ ST Finance Leases
3
4
4
5
+ Other ST Liabilities
56
26
13
12
+ Deferred Revenue
30
25
13
7
+ Derivatives & Hedging
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Misc ST Liabilities
25
1
- -
5
Total Current Liabilities
101
92
61
61
+ LT Debt
8
15
8
38
+ LT Borrowings
6
13
7
34
+ LT Finance Leases
2
2
1
4
+ Other LT Liabilities
8
7
2
18
+ Accrued Liabilities
7
6
1
16
+ Pension Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Misc LT Liabilities
1
1
1
2
Total Noncurrent Liabilities
16
23
10
56
Total Liabilities
118
115
71
117
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
+ Share Capital & APIC
27
37
63
73
+ Common Stock
- -
- -
- -
- -
+ Additional Paid in Capital
27
37
63
73
- Treasury Stock
- -
- -
3
8
+ Retained Earnings
103
143
189
240
+ Other Equity
-25
-38
-54
-57
Equity Before Minority Interest
105
142
195
248
+ Minority/Non Controlling Interest
3
2
- -
15
Total Equity
108
144
195
263
Total Liabilities & Equity
225
259
266
380
Shares Outstanding
101
101
103
103
Number of Employees
- -
- -
- -
- -
Capital Leases - Total
6
6
6
9
Net Debt
-41
-86
-118
-121
Net Debt to Equity
-38.43
-60.14
-60.72
-45.93
Tangible Common Equity Ratio
45.12
51.16
72.66
63.08
Current Ratio
1.12
1.79
3.01
3.78
Cash Conversion Cycle
- -
-71.87
-81.86
-43.17

Cash Flow Statement (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
6
39
47
51
+ Depreciation & Amortization
6
12
4
3
+ Non-Cash Items
-1
8
17
-3
+ Stock-Based Compensation
- -
- -
13
- -
+ Deferred Income Taxes
-4
4
-14
5
+ Asset Impairment Charge
1
- -
16
- -
+ Other Non-Cash Adj
2
3
3
-8
+ Chg in Non-Cash Work Cap
-11
-8
-47
-27
+ (Inc) Dec in Accts Receiv
-10
-6
13
4
+ (Inc) Dec in Inventories
-1
-2
1
- -
+ (Inc) Dec in Prepaid Assets
-6
1
- -
1
+ Inc (Dec) in Accts Payable
17
8
-45
-20
+ Inc (Dec) in Other
-12
-8
-16
-11
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Operating Activities
- -
51
21
25
+ Change in Fixed & Intang
- -
- -
- -
- -
+ Disp in Fixed & Intang
2
8
- -
7
+ Disp of Fixed Prod Assets
2
8
- -
7
+ Disp of Intangible Assets
- -
- -
- -
- -
+ Acq of Fixed & Intang
-25
-11
-3
-3
+ Acq of Fixed Prod Assets
-25
-10
-3
-3
+ Acq of Intangible Assets
- -
-2
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
-5
+ Increase in Capital Stock
- -
- -
- -
- -
+ Decrease in Capital Stock
- -
- -
- -
-5
+ Net Change in LT Investment
-3
2
- -
-1
+ Dec in LT Investment
- -
4
- -
- -
+ Inc in LT Investment
-3
-2
- -
-1
+ Net Cash From Acq & Div
-6
1
-5
-43
+ Cash from Divestitures
- -
1
- -
- -
+ Cash for Acq of Subs
-6
- -
-5
-43
+ Cash for JVs
- -
- -
- -
- -
+ Other Investing Activities
-1
2
-1
18
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Investing Activities
-33
2
-10
-21
+ Dividends Paid
- -
- -
- -
- -
+ Net Cash From Debt
-5
4
12
33
+ Cash From Debt
- -
12
12
35
+ Repayments of Debt
-5
-9
- -
-2
+ Other Financing Activities
-3
3
11
10
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Financing Activities
-8
6
23
38
Effect of Foreign Exchange Rates
-12
-7
-11
-3
Net Changes in Cash
-41
59
33
42
EBITDA
27
83
89
70
EBITDA Margin (%)
15.66
43.05
43.41
40.42
Free Cash Flow
-25
39
17
22
Net Cash Paid for Acquisitions
6
-1
5
43
Free Cash Flow to Firm
-25
39
17
22
Free Cash Flow to Equity
- -
53
29
63
Free Cash Flow per Basic Share
- -
- -
- -
- -
Price/Free Cash Flow
- -
- -
- -
- -
Cash Flow to Net Income
-0.01
1.29
0.44
0.48
Capital Expenditures
-25
-11
-3
-3